YPEG-Filgrastim

pegylated filgrastim · Xiamen Amoytop Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YPEG-Filgrastim, covering 2013-02-04 to 2013-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of YPEG-Filgrastim in Chemotherapy Patients [Phase 1]

See pricing